Analyst Insights and Signify Premium Insights

This insight provides an overview of the key developments witnessed at HIMSS from our teams that were in attendance in Orlando earlier this month. The insight is broken down into four areas of the healthcare technology industry:

The Hospital-at-Home market has received much attention in the wake of the COVID-19 Pandemic as a means to alleviate hospital bed shortages, reduce costs, and improve health outcomes for appropriate patients. Advances in remote patient monitoring technologies and a supportive policy environment offer much promise, but formidable obstacles remain.

The Infusion market has seen various swings in competitive dynamics in recent years. Product recalls, company acquisitions, new product launches, component supply issues and the uptick in demand seen following the COVID-19 pandemic have all had their impact on the market environment. This insight provides a deeper dive into the evolution of the infusion market and subsequent impact on share of the leading players.

The global fetal monitoring market reached $190 million in 2023 and is forecast to rise to $230 million in 2028. This article provides a brief snapshot of some of these major trends.

 The Clinical Care market has seen a plethora of market trends in recent years with the COVID-19 pandemic having the pinnacle effect on growth dynamics and opportunities in most markets. Component and supply issues subsided, and product demand started to rebalance in 2023, as the market adjusted to the newer way in which healthcare is provided. As we head into 2024, many Clinical Care vendors will be seeking opportunities to maximise on the healthcare reset in many regions. This insight discusses the top five trends Signify Research predicts for the Clinical Care market in 2024.

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death. Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyse and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease.

Our team of top analysts have reviewed their beginning-of-year predictions for 2023 and provided a summary of how close our predictions were to manifesting in reality.  Despite a tumultuous year of changing economic, political, and regulatory macro-influences, big technology lay-offs and the rapid emergence of potentially disruptive technology such as generative AI, most of our predictions held up, with only a few expectations missing the mark, or the timing of actual realisation being slightly off (see our 2024 predictions for more on this). 

Signify Research recently updated its analysis of the Infusion Pumps market. In the second edition of the global report, Signify Research noted a downgrade in its previous market projections for 2022 on the basis of purchasers being more cautious post-pandemic. Product recalls, supply constraints, market saturation and ongoing inflationary pressures continued to hamper revenue growth.

Analysts from the Medical Imaging and Clinical Care teams recently descended on the MEDICA Trade Fair held in Dusseldorf, Germany. Claiming to be the world’s largest medical show, MEDICA housed over 5,300 exhibitors from over 70 countries during its four-day event. We provide our thoughts on the key trends and developments the analyst team saw whilst at the event.